Radiosynthesis and biodistribution of a prosthetic group ( 18F-FENMA) conjugated to cyclic RGD peptides

Bioconjugate Chemistry

Volumn 21, Issue 12, 2010, Pages 2297-2304

  Olberg, Dag Erlend ^a   Cuthbertson, Alan ^b   Solbakken, Magne ^b   Arukwe, Joseph M ^b   Qu, Hong ^c   Kristian, Alexandr ^d   Bruheim, Skjalg ^d   Hjelstuen, Ole Kristian ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b GE HEALTHCARE   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDES; PH; PLASMA STABILITY; PROSTHETICS; TUMORS;

BIODISTRIBUTIONS; BLOCKINGS; FUNCTIONALIZED; IN-VIVO; MICHAEL ACCEPTORS; MICRO PETS; NITROSTYRENE; PROSTHETIC GROUPS; RADIOSYNTHESIS; RGD PEPTIDE;

MAMMALS;

O [2 (2 FLUOROETHOXY)ETHYL] N METHYLHYDROXYLAMINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG BLOOD LEVEL; DRUG BONE LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG LIVER LEVEL; DRUG MUSCLE LEVEL; DRUG STABILITY; DRUG SYNTHESIS; DRUG TUMOR LEVEL; DRUG UPTAKE; HEAD; IN VIVO STUDY; INTESTINE; ISOTOPE LABELING; KIDNEY; MOUSE; NONHUMAN; OSTEOSARCOMA; POSITRON EMISSION TOMOGRAPHY; SKIN; SPLEEN; TUMOR XENOGRAFT;

MUS;

EID: 78650413208     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc1003229     Document Type: Article

References (41)

1. Volkow, N. D., Mullani, N. A., and Bendriem, B. (1988) Positron emission tomography instrumentation: an overview Am. J. Physiol. Imaging 3, 142-53
2. 18F]fluoride ion Eur. J. Org. Chem. 17, 2853-73
3. Helus, F., Maier-Borst, W., Sahm, U., and Wiebe, L. I. (1979) The fluorine-18 cyclotron production methods Radiochem. Radioanal. Lett. 38, 395-410
4. Guillaume, M., Luxen, A., Nebeling, B., Argentini, M., Clark, J. C., and Pike, V. W. (1991) Recommendations for fluorine-18 production Appl. Radiat. Isot. 42, 749-62
5. +-emitting compounds based on fluorine-18 Top. Curr. Chem. 222, 201-258
6. Okarvi, S. M. (2001) Recent progress in fluorine-18 labelled peptide radiopharmaceuticals Eur. J. Nucl. Med. 28, 929-938
7. Poethko, T., Schottelius, M., Thumshirn, G., Herz, M., Haubner, R., Henriksen, G., Kessler, H., Schwaiger, M., and Welter, H. J. (2004) Chemoselective pre-conjugate radiohalogenation of unprotected mono- and multimeric peptides via oxime formation Radiochim. Acta 92, 317-327
8. Glaser, M. and Robins, E. G. (2009) Click labelling in PET radiochemistry J. Labelled. Compd. Radiopharm. 52, 407-414
9. Kilbourn, M. R., Dence, C. S., Welch, M. J., and Mathias, C. J. (1987) Fluorine-18 labeling of proteins J. Nucl. Med. 28, 462-470
10. Bruus-Jensen, K., Poethko, T., Schottelius, M., Hauser, A., Schwaiger, M., and Wester, H. J. (2006) Chemoselective hydrazone formation between HYNIC-functionalized peptides and 18F-fluorinated aldehydes Nucl. Med. Biol. 33, 173-183
11. 18F]fluorinated aldehyde-containing prosthetic groups Bioconjugate Chem. 19, 951-957
12. 3 integrin expression Eur. J. Nucl. Med. Mol. Imaging 34, 1823-1831
13. 3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4) J. Nucl. Med. 48, 1536-1544
14. Olberg, D. E., Hjelstuen, O. K., Solbakken, M., Arukwe, J., Karlsen, H., and Cuthbertson, A. (2008) A novel prosthetic group for site-selective labeling of peptides for positron emission tomography Bioconjugate Chem. 19, 1301-1308
15. Olberg, D. E., Hjelstuen, O. K., Solbakken, M., Arukwe, J. M., Dyrstad, K., and Cuthbertson, A. (2009) Site-specific addition of an 18F-N- methylaminooxy-containing prosthetic group to a vinylsulfone modified peptide J. Labelled Compd. Radiopharm. 52, 571-575
16. Indrevoll, B., Kindberg, G. M., Solbakken, M., Bjurgert, E., Johansen, J. H., Karlsen, H., Mendizabal, M., and Cuthbertson, A. (2006) NC-100717: A versatile RGD peptide scaffold for angiogenesis imaging Bioorg. Med. Chem. Lett. 16, 6190-6193
17. Jia, B., Liu, Z., Shi, J., Yu, Z., Yang, Z., Zhao, H., He, Z., Liu, S., and Wang, F. (2008) Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer Bioconjugate Chem. 19, 201-210
18. Park, J. and Pei, D. (2004) Trans-β-nitrostyrene derivatives as slow-binding inhibitors of protein tyrosine phosphatases Biochemistry 43, 15014-1521
19. Fodstad, O., Brogger, A., Bruland, O., Solheim, O. P., Nesland, J. M., and Pihl, A. (1986) Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma Int. J. Cancer 38, 33-40
20. Bernasconi, C. F., Renfrow, R. A., and Tia, P. R. (1986) Nucleophilic addition to olefins. 16. Unusual substituent effects in the reaction of amines with beta-nitrostyrenes. Solvent effect on intrinsic rate constants J. Am. Chem. Soc. 108, 4541-4549
21. 2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation Nat. Med. 3, 177-182
22. Stubbs, M., McSheehy, P. M. J., and Griffiths, J. R. (1999) Causes and consequences of acidic pH in tumors: a magnetic resonance study Adv. Enzyme Regul. 39, 13-30
23. Horiuchi, K., Saji, H., and Yokoyama, A. (1998) Tc(V)-DMS tumor localization mechanism: a pH-sensitive Tc(V)-DMS-enhanced target/nontarget ratio by glucose-mediated acidosis-Preparation and labeling condition studies J. Nucl. Biol. Med. 25, 549-555
24. Lewis, M. R. and Shively, J. E. (1998) Maleimidocysteineamido-DOTA derivatives: New reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions Bioconjugate Chem. 9, 72-86
25. Williams, L. E., Lewis, M. R., Bebb, G. G., Clarke, K. G., Odom-Maryon, T. L., Shively, J. E., and Raubitschek, A. A. (1998) Biodistribution of 111In- and 90Y-Labeled DOTA and maleimidocysteineamido-DOTA conjugated to chimeric anticarcinoembryonic antigen antibody in xenograft-bearing nude mice: Comparison of stable and chemically labile linker systems Bioconjugate Chem. 9, 87-93
26. Dijkgraaf, I., Beer, A. J., and Wester, H. J. (2009) Application of RGD-containing peptides as imaging probes for alphavbeta3 expression Front. Biosci. 14, 887-899
27. 3 integrin antagonists: a new class of tracers for tumor targeting J. Nucl. Med. 40, 1061-1071
28. 3-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics Eur. J. Nucl. Med. Mol. Imaging 36, 1874-1884
29. 3 integrin by multimerisation of RGD peptides Eur. J. Nucl. Med. Mol. Imaging 34, 267-273
30. 3 expression Bioconjugate Chem. 18, 1987-1994
31. Liu, Z., Liu, S., Wang, F., Liu, S., and Chen, X. (2009) Noninvasive imaging of tumor integrin expression using 18F-labeled RGD dimer peptide with PEG4 linkers Eur. J. Nucl. Med. Mol. Imaging 36, 1296-1307
32. 18F]fluorobenzoate Appl. Radiat. Isot. 59, 43-48
33. Liu, Z., Liu, S., Wang, F., Liu, S., and Chen, X. (2009) Noninvasive imaging of tumor integrin expression using 18F-labeled RGD dimer peptide with PEG4 linkers Eur. J. Nucl. Med. Mol. Imaging 36, 1296-1307
34. Wester, H. J. and Schottelius, M. (2007) Fluorine-18 labeling of peptides and proteins. PET Chemistry-The driving force in molecular imaging (Schubiger, A. P., Lehmann, L., and Friebe, M., Eds.) pp 80-104, Chapter 4, Springer, Berlin.
35. 18F] fluoropropanethiol Amino Acids 37, 717-724
36. 3 integrin expression J. Nucl. Med. 47, 1172-1180
37. 3 expression Eur. J. Nucl. Med. Mol. Imaging 35, 1100-1108
38. 3 integrin expression using18F-labeled RGD-containing glycopeptide and positron emission tomography Cancer Res. 61, 1781-1785
39. Mulder, W., Castermans, K., van Beijnum, J., oude Egbrink, M. G., Chin, P. T., Fayad, Z. A., Löwik, C. W., Kaijzel, E. L., Que, I., Storm, G., Strijkers, G. J., Griffioen, A. W., and Nicolay, K. (2009) Molecular imaging of tumor angiogenesis using αvβ3 targeted multimodal quantum dots Angiogenesis 12, 17-24
40. Pasqualini, R., Koivunen, E., and Ruoslahti, E. (1997) αv integrins as receptors for tumor targeting by circulating ligands Nat. Biotechnol. 15, 542-546
41. Folkman, J. (1971) Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 285, 1182-1186